Doxazosin for the Treatment of Benign Prostatic Hyperplasia in Patients with Mild to Moderate Essential Hypertension
Authors:
- Jay Y. GillenwaterJGJay Y. Gillenwater
- Richard L. ConnRCRichard L. Conn
- Steven G. ChrysantSCSteven G. Chrysant
- Johnny RoyJRJohnny Roy
- Michael GaffneyMGMichael Gaffney
- Kathleen IceKIKathleen Ice
- Norma DiasNDNorma Dias
- 1 July 1995
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- p. 110-115
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- A three month double‐blind study of doxazosin as treatment for benign prostatic bladder outlet obstructionBritish Journal of Urology, 1994
- A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic HyperplasiaJournal of Urology, 1992
- The relative efficacy of terazosin versus terazosin and flutamide for the treatment of symptomatic BPHThe Prostate, 1992
- Alfuzosin for treatment of benign prostatic hypertrophyThe Lancet, 1991
- Pharmacokinetic overview of doxazosinThe American Journal of Cardiology, 1987
- Efficacy and safety of doxazosin in hypertension therapyThe American Journal of Cardiology, 1987
- Alpha-Adrenergic Activity and Urethral Pressure in Prostatic Zone in Benign Prostatic HypertrophyJournal of Urology, 1982
- Bladder Outflow Obstruction Treated with PhenoxybenzamineBritish Journal of Urology, 1982
- A Placebo‐controlled Double‐blind Study of the Effect of Phenoxybenzamine in Benign Prostatic ObstructionBritish Journal of Urology, 1978
- Adrenergic and Cholinergic Receptors in the Human Prostate, Prostatic Capsule and Bladder NeckBritish Journal of Urology, 1975